José Gutierrez-Rodriguez , Jaime Rodríguez-Salazar , Francisco José Tarazona-Santabalbina
{"title":"Update on vaccines against respiratory syncytial virus (RSV): A narrative review","authors":"José Gutierrez-Rodriguez , Jaime Rodríguez-Salazar , Francisco José Tarazona-Santabalbina","doi":"10.1016/j.regg.2025.101630","DOIUrl":null,"url":null,"abstract":"<div><div>Respiratory syncytial virus (RSV) infections pose a significant challenge to healthcare systems due to their impact on older adults, particularly those who are frail. Implementing an appropriate vaccination policy for these patients could help reduce healthcare resource utilization and costs while enhancing the quality of life for elderly individuals and their families. This narrative review aims to present the latest evidence on RSV and the available vaccines. Of the five vaccines evaluated, three have demonstrated significant efficacy in individuals over 60 years of age. Based on the current evidence, it is recommended that individuals over 75 be offered RSV vaccination, with priority given to those with chronic heart or lung conditions, frailty, or who reside in long-term care facilities.</div></div>","PeriodicalId":39958,"journal":{"name":"Revista Espanola de Geriatria y Gerontologia","volume":"60 2","pages":"Article 101630"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Geriatria y Gerontologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0211139X25000101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Respiratory syncytial virus (RSV) infections pose a significant challenge to healthcare systems due to their impact on older adults, particularly those who are frail. Implementing an appropriate vaccination policy for these patients could help reduce healthcare resource utilization and costs while enhancing the quality of life for elderly individuals and their families. This narrative review aims to present the latest evidence on RSV and the available vaccines. Of the five vaccines evaluated, three have demonstrated significant efficacy in individuals over 60 years of age. Based on the current evidence, it is recommended that individuals over 75 be offered RSV vaccination, with priority given to those with chronic heart or lung conditions, frailty, or who reside in long-term care facilities.
期刊介绍：
Una revista de gran prestigio por sus artículos originales de investigación y revisiones. Permite cubrir todas las áreas de la medicina pero siempre desde la atención al paciente anciano, y está presente en los más reconocidos índices internacionales.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
